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dose of sarin leads to approximately half of the animals developing seizures. Whereas
previous studies analyzed transcriptomic effects associated with seizing sarin-exposed
rats, our study focused on the cohort of sarin-exposed rats that did not develop seizures.
We analyzed the genomic changes occurring in sarin-exposed, non-seizing rats and
compared differentially expressed genes and pathway activation to those of seizing rats.
At the earliest time point (0.25 h) and in multiple sarin-sensitive brain regions, defense
response genes were commonly expressed in both groups of animals as compared to the
control groups. All sarin-exposed animals activated the MAPK signaling pathway, but only
the seizing rats activated the apoptotic-associated JNK and p38 MAPK signaling sub-
pathway. A unique phenotype of the non-seizing rats was the altered expression levels of
genes that generally suppress inﬂammation or apoptosis. Importantly, the early transcrip-
tional response for inﬂammation- and apoptosis-related genes in the thalamus showed
opposite trends, with signiﬁcantly down-regulated genes being up-regulated, and vice4
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b r a i n r e s e a r c h 1 6 1 8 ( 2 0 1 5 ) 1 3 6 – 1 4 8 137versa, between the seizing and non-seizing rats. These observations lend support to the
hypothesis that regulation of anti-inﬂammatory genes might be part of an active and
sufﬁcient response in the non-seizing group to protect against the onset of seizures. As
such, stimulating or activating these responses via pretreatment strategies could boost
resilience against nerve agent exposures.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Highly toxic organophosphate (OP) nerve agents, such as
sarin (O-isopropyl methylphosphonoﬂuoridate), inhibit acet-
ylcholinesterase (AChE), an enzyme that hydrolyzes and
regulates the neurotransmitter acetylcholine (ACh). The inac-
tivation of AChE causes a toxic buildup of postsynaptic ACh
and results in the overstimulation of muscarinic and nico-
tinic ACh receptors (McDonough and Shih, 1997). Systemic
damage follows a three-phase neuropharmacological process
in which 1) the initial hyperstimulation of the cholinergic
receptors by excess ACh initiates seizures, followed by 2) a
predominantly glutamatergic phase that sustains the seizure,
and 3) a ﬁnal state where the excessive stimulation of
ionotropic glutamate receptors causes excessive elevations
in intracellular sodium and calcium concentrations. This
imbalance of ions, especially the increase in intracellular free
calcium, produces a harmful cascade of pathological pro-
cesses leading to excitotoxic cell death (McDonough and Shih,
1997). Seizure duration and intensity are correlated with
neuronal injury and irreversible brain damage (Tanaka
et al., 1996). In animal models, signs of neuropathology are
evident after 20 min of seizures, and seizures lasting 40 min
are more difﬁcult to terminate (Myhrer, 2007). Thus, under-
standing how seizures are initiated or inhibited at the cellular
level is critical for understanding damage prevention and
countermeasure development.
To understand the mechanism of seizures, previous stu-
dies (Spradling et al., 2011a, 2011b) have analyzed the tran-
scriptomic responses in ﬁve nerve agent-sensitive brain
regions (Aroniadou-Anderjaska et al., 2009; Myhrer, 2007;
Myhrer et al., 2007) at different time intervals (0.25 h, 1 h,
3 h, 6 h, and 24 h) in rats following sarin-induced seizures. In
these experiments, approximately half of the rats exposed to
a 1LD50 (median lethal dose) concentration of sarin devel-
oped seizures (Fig. 1a). The extensive activation of inﬂam-
matory responses in the seizing rats, in particular by
neurotoxic and pro-inﬂammatory cytokines, such as Il-1β,
Tnf-α, and Il-6, was observed in all brain regions (Spradling
et al., 2011a, 2011b), consistent with ﬁndings from previous
studies (Chapman et al., 2006; Dhote et al., 2007; Dillman
et al., 2009; Johnson and Kan, 2010; Svensson et al., 2001,
2005; Williams et al., 2003).
In contrast, our study was focused on the roughly half of
the sarin-exposed rats that did not develop seizures
(Spradling et al., 2011a). Even though half of the animals
given a dose of 1LD50 are affected by seizures leading todeath (if left untreated), the remaining non-seizing animals
will be affected by sarin at these exposure levels, and non-
lethal damage and subsequent long-term sequelae cannot be
ruled out for this group. The differences in seizure onset are
part of the natural variability in the biological response
capacity to overcome the sarin insult and do not represent
an experimental artifact. Thus, this study addresses the
difference in this biological response and attempts to identify
the underlying molecular pathways responsible for avoiding
the onset of seizures in the non-seizing group.
We hypothesized that endogenous neuroprotective
mechanisms helped this group respond to sarin intoxication
and that this response was reﬂected in global changes in RNA
levels from non-seizing rats. Thus, a comparison between
seizing and non-seizing sarin-exposed rats could help us
better understand both pathological and defense mechan-
isms involved in the response to OP nerve agents. These
mechanisms could further be exploited for implementing
novel potential neuroprotective therapeutic strategies that
could mediate the cascade of secondary events leading to
brain damage (Tang et al., 2011). Importantly, our analysis
determined that there were both commonalities and sub-
stantial differences between the seizing and non-seizing rat
responses, and that the non-seizing response was speciﬁcally
tied to neuroprotection via the differential activation of anti-
inﬂammatory and anti-apoptotic pathways.2. Results
We determined the differentially expressed genes (DEGs) from
the data of Spradling et al. (2011b), using a false discovery rate
(FDR)-corrected p-value cutoff of 0.05 for each of the ﬁve studied
brain regions (amygdala, hippocampus, piriform cortex, septum,
and thalamus) and at each time point (0.25 h, 1 h, 3 h, 6 h, and
24 h). The determination of the DEGs from each cohort of seizing
and non-seizing rats employed separate control groups due to
differences in countermeasure administration. Seizing rats and
their controls were given the countermeasures atropine sulfate
and 2-pyridine aldoxime methylchloride (2-PAM) within one
minute of seizure onset, followed by the anticonvulsant diaze-
pam 0.50 h later. Non-seizing rats and their controls received no
countermeasures (Fig. 1a). Fig. 1b and c shows the total number
of up- and down-regulated genes in either group as a function of
time and brain region. Although the number of DEGs was
comparable at 0.25 h, the continued transcriptional response in
the seizing group was substantial and still increasing at 24 h. In
b r a i n r e s e a r c h 1 6 1 8 ( 2 0 1 5 ) 1 3 6 – 1 4 8138order to characterize the initial differences and similarities
between the seizing and non-seizing group, we focused on the
0.25-h time point, i.e., before the anticonvulsant was
administered.0
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Up-regulated genes2.1. Seizing and non-seizing rat transcriptional response
at 0.25 h
Table 1 shows the number of different and common down-
and up-regulated genes and their distribution in the investi-
gated brain regions for the seizing and non-seizing groups. In
general, the number of up-regulated genes was larger than
the number of down-regulated genes (179 versus 96 in seizing
rats and 121 versus 97 in non-seizing rats). The gene overlap
between the seizing and non-seizing groups ranged from 13%
for the down-regulated genes to 17–25% among the up-
regulated genes. Among the down-regulated genes, the
amygdala had the largest number of common genes between
the two groups; i.e., out of the 17 (47) genes for seizing (non-
seizing) animals, 11 were common to both groups. Table 2
lists the identity of these genes and highlights the common-
ality of the up-regulated genes among the brain regions. Five
genes, Btg2, Dusp1, Ier2, Ilf3, and Zfp36, were common to at
least four brain regions between the seizing and non-seizing
groups. The immediate early response gene Fos was also up-
regulated in the hippocampus and thalamus of both groups,
although the intensity of this up-regulation became signiﬁ-Fig. 1 – Deﬁnition of seizing/non-seizing animal groups
and number of differentially expressed genes. (A) A
diagram of the different groups of rats in the experiment
(Spradling et al., 2011a). Rats were challenged with 1LD50
sarin. Approximately half of the sarin-exposed rats
developed seizures (seizing rats) and were injected with
countermeasure treatments. The corresponding control
group for seizing rats was also injected with
countermeasure medicines. The sarin-exposed rats that
did not develop seizures (non-seizing rats) and their
corresponding controls did not receive countermeasure
treatments. All control rats received saline injections in
lieu of sarin. (B) The number of genes differentially down-
regulated, and (C) up-regulated in the ﬁve sarin-sensitive
brain regions of seizing and non-seizing rats. Ng: number
of genes; S: seizing; NS: non-seizing.
Table 1 – Total number of down-regulated and up-
regulated genes in the sarin-sensitive brain regions that
are unique to each group of animals as well as the
differentially expressed genes found to be common to
both groups at 0.25 h.
Seizing Common Non-seizing
Down-regulated genes
Amygdala 17 11 47
Hippocampus 1 0 10
Piriform 65 2 17
Septum 8 0 7
Thalamus 5 0 16
Up-regulated genes
Amygdala 32 5 18
Hippocampus 43 8 22
Piriform 41 4 15
Septum 21 4 30
Thalamus 42 10 36
Fig. 2 – Activated and suppressed Gene Ontology (GO) terms
(blue text) and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways (black text) related to the three-phase model
of sarin-induced seizure. Based on the differentially expressed
genes in the brain regions at 0.25 h, a number of GO terms and
KEGG pathways may be involved in the cholinergic,
intermediate, and glutamatergic phases of seizure, as well as in
the consequences from the activation of receptors in those
phases (i.e., calcium ion levels, downstream signaling
pathways, apoptosis). Each observation is statistically
signiﬁcant, with an associated p-valueo0.05. A: amygdala; H:
hippocampus; P: piriform cortex; S: septum; T: thalamus.
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all brain regions at 24 h, Fos was up-regulated in seizing rats,
with an average log2 fold change (FC) of 4.47 (σ¼0.70),
compared to 1.46 (σ¼0.40) for the non-seizing group.
2.1.1. Activation of cholinergic and glutamatergic stress-
related genes
We determined the enriched Gene Ontology (GO) terms and
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways
that were associated with the DEGs at the earliest time point
and were related to the different phases (McDonough and
Shih, 1997) for sarin-induced seizures. Fig. 2 shows the gross
difference in activation of these phases for the seizing versus
non-seizing animals, in particular the overall low activation
of downstream inﬂammatory signaling pathways for the
non-seizing animals.
For the cholinergic-related pathways, only the thalamus of
non-seizing rats showed a transcription response by up-
regulation of Chrna3 and the choline transporter Slc5a7 (p-
value¼0.02). On the other hand, only the thalamus of seizing
rats showed a consistent up-regulation of glutamate secre-
tion through expression of Avp and Il-1β (p-value¼0.04). The
thalamus of seizing rats was also associated with an elevated
cytosolic calcium ion concentration through up-regulating
transcription of Avp, Ccl3, Hcrt, Il-1β, and Pmch (p-
value¼810–6). The most notable difference between the
two groups was the large number of KEGG pathways asso-
ciated with inﬂammation activated in the seizing group
(Fig. 2). The exception in the non-seizing group was the
partial activation of the MAPK signaling pathway in two brain
regions in non-seizing rats.
2.2. MAPK signaling pathway activation
We examined the number of DEGs involved with the MAPK
signaling pathway as a function of time and brain region forTable 2 – Common down-regulated and up-regulated genes at 0.25 h in each brain region. Five genes (shown in bold text)
were common in at least four brain regions: Btg2, Dusp1, Ier2, Ilf3, and Zfp36.
Amygdala Hippocampus Piriform Septum Thalamus
Down-regulated genes
Coch – Nqo2 – –
Col1a2 – – – –
Colec12 – – – –
Cp – – – –
Fmod – – – –
Gjb2 – – – –
Igf2 – – – –
Ogn – Ogn – –
Serping1 – – – –
Slc6a13 – – – –
Slc6a20 – – – –
Up-regulated genes
– – – – Atf3
Btg2 Btg2 – Btg2 Btg2
Dusp1 Dusp1 Dusp1 Dusp1 Dusp1
– Fos – – Fos
Ier2 Ier2 Ier2 – Ier2
– – – – Iﬁt3
Ilf3 Ilf3 Ilf3 Ilf3 Ilf3
– Ogn – – Junb
– Ttr – – Oxt
Zfp36 Zfp36 Zfp36 Zfp36 Zfp36
b r a i n r e s e a r c h 1 6 1 8 ( 2 0 1 5 ) 1 3 6 – 1 4 8140both the seizing and non-seizing groups. Fig. 3a shows the
increased number of up-regulated MAPK-associated genes for
the seizing group as a function of time; in the non-seizing
group, the number of MAPK-related genes was roughly
similar at the earliest and latest time points.2.2.1. Differential activation of MAPK sub-pathways
We further analyzed the DEGs in the MAPK signaling path-
way in terms of differential activation of the classical versus
the distinct JNK and p38, and ERK5 sub-pathways. Fig. 3b
shows the average number of DEGs from all brain regions for-1
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Fig. 4 – A representation of part of the JNK and p38 MAPK
signaling pathway. (A) The binding of cytokines such as
interleukin-1β to its receptor can trigger the activation of the
JNK and p38 MAPK signaling pathway. (B) The log2 fold-
change of Il-1β as a function of time in the different sarin-
sensitive regions of the brain in seizing and non-seizing
rats. Il-1β: interleukin-1β; FC: log2 fold-change; NS: non-
seizing; S: seizing.
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Fig. 3 – Up-regulated genes in the MAPK signaling pathway.
(A) The number of genes up-regulated in the MAPK signaling
pathway in the ﬁve sarin-sensitive brain regions of seizing
and non-seizing rats. (B) The average number of up-
regulated genes in the three MAPK signaling sub-pathways.
Ng: number of genes; S: seizing; NS: non-seizing; oNg4:
average Ng.these pathways for both the seizing and the non-seizing
groups. There was no difference in the time proﬁle between
the groups in the ERK5 pathway, and, with the exception of
the 1-h and 3-h time points (with p-values of 0.02 and 0.05,
respectively), there was also no signiﬁcant difference bet-
ween the number of DEGs in the classical MAPK signaling
sub-pathway in seizing and non-seizing rats. In contrast, the
transcriptional response in the non-seizing group showed no
evidence of elevated levels of genes from the JNK and p38
MAPK signaling sub-pathway, whereas the number of genes
for the seizing group was signiﬁcantly elevated for all time
points (p-valueo0.05). Supplementary Fig. 1 provides the FC
for all genes activated by seizing rats in this sub-pathway.
We also examined the genes that could trigger the JNK and
p38 MAPK signaling sub-pathway (Fig. 4a) and observed the
up-regulation of Il-1β in seizing rats at 0.25 h (Fig. 4b). The
overexpression of Il-1β in seizing rats at 0.25 h was compa-
tible with the activation of apoptosis through the JNK and p38
pathways (Abraham and Clark, 2006). The onset of apoptosis
in this group was evident at later time points by the up-
regulation of several gene transcripts associated with
apoptosis-related genes: Caspase 3, Myc, Hmox1, and Bcl3
were up-regulated in multiple brain regions at later time
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Fig. 5 – Expression of Homer1 and Ephx2. (A) The log2 fold-
change of Homer1 at different time points in the ﬁve sarin-
sensitive brain regions in seizing and non-seizing rats. (B)
The time-dependent log2 fold-change of Ephx2. FC: log2 fold-
change; NS: non-seizing; S: seizing.
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no evidence of up-regulation or activation of apoptosis in the
non-seizing animals.
2.3. Altered gene transcription levels between non-seizing
and seizing animals
To investigate the differences between seizing and non-
seizing rats, we identiﬁed 1) sets of genes common to at least
three brain regions, whose transcription levels signiﬁcantly
increased or decreased compared to controls, and whose
levels did not change among the seizing animals at the
earliest time point; 2) sets of “opposing” genes in speciﬁc
brain regions that exhibited opposite up/down or down/up
transcriptional levels among the seizing/non-seizing groups;
and 3) GO terms related to either immune response or
neurological function.
2.3.1. Common genes differentially expressed in brain regions
of non-seizing rats
Table 3 shows the three genes that were differentially over-
expressed at 0.25 h in at least three of the ﬁve sarin-sensitive
brain regions of non-seizing rats: Homer1, Bcat1, and Ttr. In
seizing rats, the expression levels of these genes were gen-
erally not signiﬁcantly different from the levels in the control
group. Fig. 5a and Supplementary Fig. 3a show the detailed
time course and brain-region-speciﬁc expression-level
changes for these genes. The initial increased mRNA expres-
sion levels of Homer1 in all brain regions in the non-seizing
animals were followed by a decrease at 1 h, then an increase.
The seizing animals lacked the initial onset, but showed
stronger and sustained levels of Homer1 expression beyond
the 3-h time point.
Table 4 shows the ﬁve genes that were differentially
under-expressed at 0.25 h in at least three of the ﬁve sarin-
sensitive brain regions of non-seizing rats: Ephx2, Retsat,
Nqo2, Dbp, and Zeb2. In seizing rats, the expression levels of
these genes were not signiﬁcantly different from levels in the
control group. Fig. 5b and Supplementary Fig. 3b show the
corresponding brain region and time-dependent mRNA
expression-level changes relative to the control groups
beyond the 0.25-h time point. Interestingly, the pattern for
expression of Ephx2 was negatively correlated between the
seizing and non-seizing groups (Fig. 5b), with an average
Pearson coefﬁcient of 0.93 for all the brain regions, with
individual values ranging from 0.87 to 0.98. Ephx2 expres-
sion levels were down in the non-seizing group until 3 h, after
which the expression levels returned to control group levels.
We also observed moderately anti-correlated time-dependentTable 3 – Up-regulated genes found at 0.25 h in at least three
Gene Possible neuroprotective function
Homer1  Regulates apoptosis
 Strongly attenuates calcium mobilization and M
induced by glutamate receptors
Bcat1  Key enzyme of glutamate metabolism
Ttr  Inhibits interleukin-1 production
 Contributes to control neuronal cell death andexpression levels of Retsat in the amygdala (r¼0.44) and
hippocampus (r¼0.49), Dbp in the amygdala (r¼0.45) and
hippocampus (r¼0.53), and Zeb2 in the hippocampus
(r¼0.40) (Supplementary Fig. 3b). Anti-correlated behavior
indicated the opposing regulation of gene expression
between the two groups over the entire duration of the
experiment.brain regions in non-seizing rats but not in seizing rats.
Reference
APK activation
(Luo et al., 2012; Tappe et al., 2006)
(Madeddu et al., 2004)
inﬂammation (Borish et al., 1992; Santos et al., 2010)
Table 4 – Down-regulated genes found in at least three brain regions in non-seizing rats (but not in seizing rats) at 0.25 h.
Gene Possible neuroprotective function Reference
Ephx2  Inhibition decreased plasma levels of pro-inﬂammatory cytokines
 Suppression partially explains anti-inﬂammatory effect of estrogen
 Inhibition enhances the anti-inﬂammatory effects of aspirin and MK886
 Ephx2/ mice attenuate endotoxin-induced activation of nuclear factor
(NF)-κB signaling, chemokine and cytokine expression, and neutrophil
inﬁltration in the lung
 Inhibition reduces renal inﬂammation and injury
(Deng et al., 2011; Elmarakby et al., 2011; Koerner
et al., 2008; Liu et al., 2010; Schmelzer et al., 2005)
Retsat  Reduced expression strongly protects cells from oxidative stress (Nagaoka-Yasuda et al., 2007)
Nqo2  Loss of Nqo1 and Nqo2 leads to altered intracellular redox status,
decreased expression and activation of NF-κB, and altered chemokines
 Inhibition could prevent oxidative damage of membrane structures,
proteins, and nucleic acids (neuroprotective effect)
(Iskander et al., 2006; Kadnikov et al., 2014)
Dbp  Down-regulation occurs during chemically induced liver regeneration (Mueller et al., 1990)
Zeb2  Zeb2þ/ mice have a hypoalgesic phenotype in inﬂammatory pain (Pradier et al., 2014)
Table 5 – Genes with opposing log2 fold-change between seizing and non-seizing rats at 0.25 h.
Gene FC FC Possible neuroprotective action Reference
Seizing Non-seizing
Amygdala
Avp 1.57 1.13  Up-regulated in rat hypothalamus after
kainic-acid-induced seizures
(Iwanaga et al., 2011)
Prim1 0.97 0.78  Mutation causes extensive apoptosis (Yamaguchi et al., 2008)
Thalamus
Gja1 1.24 1.38  A mixture of tumor necrosis factor-α and interferon
γ decreases Gja1 expression
(Zhang et al., 2013)
Plekhb2 1.28 1.39  Depletion of Plekhb2 suppresses membrane trafﬁc (Uchida et al., 2011)
Ppp3r1 1.15 1.31  In cardiomyocytes, pretreatment with Ppp3r1
reduces apoptosis in response to hypoxia
 Down-regulated in traumatic brain injury
 Has inverse relationship with p38MAPK-diP
(Bodega et al., 2007; Guo et al.,
2012; Wu et al., 2013)
Prkacb 1.17 1.32  Injury to hypoglossal motor neurons decreases
Prkacb expression
(Kiryu et al., 1995)
Rnf6 1.45 1.03  High Rnf6 protein levels play a role in developing
axonal projections
(Tursun et al., 2005)
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opposing expression levels in seizing and non-seizing rats
We identiﬁed genes in speciﬁc brain regions that were up-
regulated in one cohort but down-regulated in the other, or
vice-versa. At the earliest time point of 0.25 h, reﬂective of the
initial response prior to anticonvulsant administration, there
were no genes in the hippocampus, the piriform cortex, or the
septum that showed opposing fold changes between seizing
and non-seizing animals. However, in the amygdala, Avp was
up-regulated in seizing rats and down-regulated in non-
seizing rats, whereas Prim1 showed the opposite up/down
expression-level pattern (Table 5). Although Prim1 was not
differentially expressed in any other brain region among the
non-seizing animals, it was down-regulated in the hippo-
campus and the piriform cortex in the seizing group at 0.25 h.
We found a clear pattern of the up/down behavior for ﬁve
genes in the thalamus. All ﬁve genes that were down-
regulated at 0.25 h in the thalamus of seizing rats were up-
regulated in non-seizing rats, namely: Gja1, Plekhb2, Ppp3r1,
Prkacb, and Rnf6 (Table 5). Compared to their respectivecontrols, non-seizing rats activated these genes by at least
two-fold (FC41), while seizing rats suppressed their expres-
sion by more than two-fold (FCo-1).
2.3.3. Differential expression of genes involved in immune,
defense, and neurological pathways
We analyzed the pattern of pathways impacted by the
differential and opposite levels of mRNA transcripts in the
seizing and non-seizing animal groups exposed to sarin at
the initial 0.25-h time point. Fig. 6 shows the differential GO-
term enrichment associated with different defense and
immune responses, and with nerve and synaptic transmis-
sions in the different brain regions.
The animals in the non-seizing group exhibited lowered
expression of genes that belong to the defense and immune
response categories in the amygdala and piriform cortex,
whereas these categories were associated with increased
expression levels in the piriform cortex and thalamus of the
seizing rats. Seizing rats exhibited increased expression of
genes related to the regulation of nerve impulse and synaptic
Fig. 6 – Activated and suppressed Gene Ontology (GO) terms
related to immune response and nerve impulse
transmission. Based on the differentially expressed genes in
different brain regions at 0.25 h, a number of GO terms may
be involved in immune response or nerve impulse
transmission. Each observation is statistically signiﬁcant,
with an associated p-valueo0.05. A: amygdala; H:
hippocampus; P: piriform cortex; S: septum; T: thalamus.
b r a i n r e s e a r c h 1 6 1 8 ( 2 0 1 5 ) 1 3 6 – 1 4 8 143transmission in all brain regions except the septum. These
processes were absent in the non-seizing rats, except for the
related term “transmission of nerve impulse,” which was
associated with increased expression levels in the septum
and thalamus of the non-seizing rat.3. Discussion
The data at the earliest time point (0.25 h) reﬂect the initial
and early physiological response after sarin exposure in
either non-seizing or seizing animal groups. The seizing
phenotype indicates that the animals could not overcome
the sarin intoxication using endogenous responses and that
the countermeasures administered immediately after the
onset of seizure served to reactivate non-aged AChE and
protect muscarinic acetylcholine receptors from continued
physiological damage, but did stop the seizures themselves.
On the other hand, the non-seizing rats (and their control)
received no countermeasures and represent a sufﬁcient
endogenous response to inhibit initial seizures. It was clear
from the number of differentially expressed mRNA tran-
scripts in both groups of animals that all studied brain
regions were affected by sarin at the earliest time point
(Fig. 1b and c, and Table 1). Here, we discuss the similarities
and differences between these responses in order to char-
acterize the response in the animals that did not experience
seizures from the same level of sarin exposure.
3.1. Similarities and differences between seizing and non-
seizing animal responses to the sarin insult
We observed increased mRNA transcription levels in both
seizing and non-seizing animals for ﬁve genes in at least four
brain regions (Table 2). Of these, Ier2 is an immediate early
gene, which plays a largely non-speciﬁc role as an earlier
response to cellular stress. Btg2 and Ilf3 are transcription
factors implicated in the control of neuronal differentiation
and the expression of interleukins such as Il-2 (Zhu et al.,
2010), respectively. Ilf3, together with Dusp1 and Zfp36, isassociated with regulation of the inﬂammatory response. By
phosphorylating and negatively regulating JNK and p38
MAPK, Dusp1 regulates innate immunity and can profoundly
affect the outcome of inﬂammatory challenges (Abraham and
Clark, 2006). The protein of Zfp36, tristetrapolin, promotes the
degradation of pro-inﬂammatory cytokines Tnf-α and Il-6
(Carballo et al., 1998; Zhao et al., 2011), which are known to
be up-regulated in seizing rats (Spradling et al., 2011a). We
also observed a statistically signiﬁcant increase in mRNA
transcription levels for Fos in select brain regions of both
seizing and non-seizing rats, with the latter showing levels of
less intensity. The up-regulation of the immediate early gene
Fos is seen following a convulsion-inducing dose of the OP
nerve agent soman (Denoyer et al., 1992; Zimmer et al., 1997).
Taken together, the commonality of the above DEGs in both
groups at 0.25 h points to shared components of a physiolo-
gical defense response mounted against the sarin exposure.
3.1.1. Differential activation of MAPK sub-pathways
distinguished the seizing and non-seizing responses
Among the shared pathways that were activated in both
groups (Fig. 2), we hypothesized that the details in the
activation pattern of the MAPK signaling pathway carried
important implications for the downstream inﬂammatory
responses (Herlaar and Brown, 1999; Kyriakis and Avruch,
2001). First, there was more extensive activation of the MAPK
signaling pathway at 0.25 h in the seizing rats, with ﬁve brain
regions affected, as opposed to two in the non-seizing group.
This activation also persisted at later time points, in spite of
the countermeasures given to the seizing group. Second, we
found that the activation of particular sub-pathways of the
MAPK signaling pathway differentiated the seizing from the
non-seizing animals exposed to sarin.
When we mapped all the genes up-regulated in the MAPK
signaling pathways, the number of genes involved in the
classical MAPK signaling and ERK5 MAPK signaling was
similar. Although both sub-pathways lead to proliferation
and differentiation (Abraham and Clark, 2006; Nishimoto and
Nishida, 2006), the number of up-regulated genes associated
with JNK and p38 MAPK signaling increased for seizing rats
up until 3 h and remained at an elevated number at 24 h,
while the number of JNK and p38 MAPK signaling genes for
non-seizing rats remained unaltered (Fig. 3).
The already increased levels of Il-1β at 0.25 h observed in
seizing rats (Fig. 4b), and notably absent in the non-seizing
group, serve as the potential trigger of the JNK and p38 MAPK
signaling sub-pathway in OP-induced seizures (Chapman
et al., 2006; Dhote et al., 2007; Johnson and Kan, 2010;
Svensson et al., 2001, 2005; Williams et al., 2003). Further
evidence of the role of Il-1β is its signiﬁcantly higher and
longer-lasting levels of expression in rats experiencing longer
seizures (Chapman et al., 2006), and its involvement in long-
term brain damage after OP intoxication (Svensson et al.,
2001). Importantly, animals that do not exhibit seizures
following soman intoxication did not over-express Il-1β
(Svensson et al., 2005).
The activation of potentially harmful inﬂammation
through speciﬁc MAPK pathways in the seizing animals is
likely an initial event that, if unabated, triggers apoptosis and
sustains persistent seizures (Abraham and Clark, 2006; Baille
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Zhang and Liu, 2002). On the other hand, in the non-seizing
animal, mechanisms that are able to control or inhibit the
inﬂammatory response would constitute innate neuroprotec-
tive mechanisms. Evidence for the speciﬁc activation and
suppression of such processes is discussed next.
3.2. Anti-inﬂammatory processes speciﬁcally activated in
non-seizing rats
We found groups of genes common to the non-seizing group
that were either up- or down-regulated in at least three brain
regions at the earliest time point of 0.25 h, but not differen-
tially expressed among the seizing rats. Tables 3 and 4 show
the biological processes and tentative mechanism associated
with these genes.
3.2.1. Up-regulation of genes in the non-seizing response
We found increased expression of Ttr and Homer1 in the non-
seizing group, but not in the seizing rats at the earliest time
point. These genes have been linked to anti-inﬂammatory or
anti-apoptotic processes in a number of previous studies: Ttr
was found to inhibit monocyte and endothelial cell Il-1 produc-
tion (Borish et al., 1992), and cerebrospinal ﬂuid Ttr contributes to
controlled neuronal cell death, edema, and inﬂammation
(Santos et al., 2010). Similarly, overexpression of Homer1a (the
short variant of Homer1) blocked Tnf-α/cycloheximide-induced
apoptotic cell death (Luo et al., 2012). Homer1a is rapidly and
selectively up-regulated in spinal cord neurons after peripheral
inﬂammation in an N-methyl-D-aspartate (NMDA) receptor-
dependent manner, strongly attenuating calcium mobilization
as well as MAPK activation induced by glutamate receptors
(Tappe et al., 2006).
3.2.2. Down-regulation of genes in the non-seizing response
We found decreased expression of Ephx2, Retsat, Nqo2, and Zeb2
in at least three brain regions in non-seizing rats (but not in
seizing rats) at 0.25 h. Ephx2 has been linked to inﬂammation via
both drug inhibition and knockout experiments. Inhibitors of
soluble epoxide hydrolase 2 (sEH, the protein from Ephx2)
decreased plasma levels of pro-inﬂammatory cytokines and
nitric oxide metabolites (Schmelzer et al., 2005). Similarly, the
neuroprotection provided by estradiol against ischemic brain
injury is partially explained by sEH suppression (Koerner et al.,
2008); inhibition of sEH enhances the anti-inﬂammatory effects
of aspirin (Liu et al., 2010), and inhibition of sEH reduces renal
inﬂammation and injury in diabetic wild-type mice (Elmarakby
et al., 2011). Knockout experiments show that Ephx2/ mice
each exhibited a signiﬁcant attenuation of endotoxin-induced
activation of nuclear factor (NF)-κB signaling, cellular adhesion
molecules, chemokine and cytokine expression, and neutrophil
inﬁltration into the lungs (Deng et al., 2011).
The lowered expression of Retsat, Nqo2, and Zeb2 can also be
linked to the mitigation of inﬂammation and oxidative stress.
Speciﬁcally reducing the expression of Retsat strongly protects
cells from oxidative stress (Nagaoka-Yasuda et al., 2007). The loss
of Nqo2, together with Nqo1, leads to altered intracellular redox
status, decreased expression and activation of NF-κB, and
alteration of chemokine levels (Iskander et al., 2006). Similarly,
drug inhibition of Nqo2 could prevent oxidative damage ofmembrane structures, proteins, and nucleic acids (Kadnikov
et al., 2014). Lastly, Zeb2 was shown in a Zeb2þ/ mice knockout
experiment to decrease sensitivity to inﬂammatory pain (Pradier
et al., 2014). Thus, the decreased expressions of Ephx2, Retsat,
Nqo2, and Zeb2 were compatible with an active response aimed
at mitigating inﬂammatory stress.
3.2.3. Opposing regulation of genes in non-seizing versus
seizing animals
A third group of genes comprises those that have signiﬁcant
opposite high/low or low/high expression levels that differ-
entiate the seizing and non-seizing groups. We observed a
number of such pairs speciﬁcally located in the amygdala and
the thalamus at the 0.25-h time point (Table 5). In the
amygdala, a brain region important for initiation and control
of seizures (Aroniadou-Anderjaska et al., 2009), 1) Avp was
down-regulated in non-seizing rats and up-regulated in seiz-
ing rats, and 2) Prim1 was up-regulated in non-seizing rats
and down-regulated in seizing rats. The state of these genes
in the seizing group has been independently linked to
seizures (Avp) (Iwanaga et al., 2011) and extensive apoptosis
(Prim1) (Yamaguchi et al., 2008).
Although not the site of seizure origin, the thalamus
regulates other structures involved in seizures (Miller and
Ferrendelli, 1990) and supports the propagation and synchro-
nization of limbic seizures (Chang et al., 2013). Furthermore,
pretreatment of the thalamus can protect against seizures
originating from the piriform cortex (Cassidy and Gale, 1998).
In the study by Spradling et al. (2011b), the thalamus was
identiﬁed as a brain region with a unique molecular response
to nerve agent-induced seizures (Spradling et al., 2011a).
At 0.25 h, we found only ﬁve down-regulated genes in the
thalamus of the seizing rats, whereas all of the genes were up-
regulated in the non-seizing rats (Table 5). Two of these genes –
Gja1 and Ppp3r1 – are known to be involved in the inﬂammation
pathway. Consistent with the pro-inﬂammatory phenotype of
the seizing animals, decreased Gja1 expression has been linked
to the presence of the inﬂammatory cytokines Tnf-α and
interferon-γ (Zhang et al., 2013), and to the inﬂammatory attack
on central nervous system white matter (Brand-Schieber et al.,
2005). Similarly, down-regulation of Ppp3r1 is associated with
traumatic brain injury (Wu et al., 2013), and its pro-inﬂammatory
activity is inversely related to p38MAPK-diP (Bodega et al., 2007).
Furthermore, pretreatment with Ppp3r1 in cardiomyocytes
reduces apoptosis in response to hypoxia (Guo et al., 2012).
3.3. Hypothesis on the role of anti-inﬂammatory processes
in non-seizing animals
The microarray analyses of the two groups of sarin-exposed rats
suggested that non-seizing rats were active in suppressing
inﬂammation related to sarin poisoning. As discussed above
and summarized in Tables 3–5, the appropriate up- or down-
regulation of the genes unique to non-seizing rats was generally
beneﬁcial in protecting cells via anti-inﬂammatory or anti-
apoptotic processes. In addition, speciﬁc brain regions in non-
seizing rats suppressed defense and immune responses, while
seizing rats activated them (Fig. 6). The transcriptional evidence
of activation of these mechanisms in non-seizing animals and
lack thereof in the seizing animals indicates an initial active
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traditional three-stage process associate with OP poisoning.
Differential activation of the MAPK inﬂammatory pathways in
the two groups was linked to downstream activation of apopto-
sis in the seizing group, but not in the non-seizing group. While
it is established that seizure causes inﬂammation, the intimate
connection between the two processes has also led to the
hypothesis that inﬂammation may cause and contribute to
seizures (Vezzani et al., 2011), a hypothesis that is also supported
by experimental results (Marchi et al., 2014; Shimada et al., 2014;
Vitaliti et al., 2014).
The response of non-seizing rats to sarin exposure included
the differential regulation of the MAPK signaling pathway, which
served to reduce a harmful inﬂammatory response. Thus, up-
regulation of Ttr and Dusp1 served to inhibit Il-1 and Tnf-α, the
latter being known triggers of the pro-apoptotic JNK and p38
MAPK signaling sub-pathways (Abraham and Clark, 2006; Borish
et al., 1992), which are related to seizure activity (Yang et al.,
1997). Similarly, the preferential up-regulation of Homer1 could
be linked to attenuation of MAPK activation (Tappe et al., 2006).
Hence, it is interesting to hypothesize that the transcriptional
activity associated with the regulation of anti-inﬂammatory
genes may in fact be part of an active and sufﬁcient response
to protect against the onset of seizures.
The observed “opposing” effects of separate sets of genes
that exhibited opposite up/down or down/up transcriptional
levels among the seizing/non-seizing groups could poten-
tially be exploited for therapeutic purposes. Pretreatments
using down-regulated genes linked to the seizing phenotypes
have shown a protective effect against inﬂammation and
injury (Guo et al., 2012). Similarly, pretreatment using NMDA
was shown to reduce the incidence of seizures up to 50%
(Boeck et al., 2004) by modulating the MAPK pathway
response (de Araújo Herculano et al., 2011). Treatment or
pre-conditioning with gene products or drugs that affect
these proteins could channel and strengthen the brain's
protective physiological response against otherwise lethal
sarin challenges.4. Experimental procedure
4.1. Data collection and processing
In our analyses, we used the publicly available gene expres-
sion microarray dataset from rat studies of sarin exposure
(Spradling et al., 2011a). In summary, male Sprague–Dawley
rats were subcutaneously challenged with 1LD50 sarin
(108 μg/kg) and, accordingly, approximately 50% of the ani-
mals challenged with sarin produced seizure activity follow-
ing exposure. Seizing rats were treated with atropine sulfate
(to block excess ACh from the muscarinic receptors) and 2-
PAM (to reactivate non-aged AChE) one minute after seizure
onset, and with the anticonvulsant diazepam 30 min later.
Matched control animals received an equivalent volume of
vehicle (saline) and countermeasure drugs corresponding to
the injections administered to seizing rats. Drug treatments
were not given to the remaining sarin-exposed rats that did
not develop seizures or to their matched controls. Fig. 1a
illustrates the four groups of rats (sarin-exposed seizing rats,sarin-exposed non-seizing rats, saline control for seizing rats,
saline control for non-seizing rats) used in the microarray
analyses. Three to four animals from each group of rats were
euthanized at time points 0.25, 1, 3, 6, and 24 h, and ﬁve
different brain regions (amygdala, hippocampus, piriform
cortex, septum, and thalamus) were immediately collected
at each time point for microarray hybridization (Spradling
et al., 2011a).
We downloaded the raw gene expression microarray
datasets with series accession number GSE28435 from the
Gene Expression Omnibus repository (http://www.ncbi.nlm.
nih.gov/geo/) in January 2014. Each microarray corresponds to
gene transcription changes in the brain regions of the rats as
caused by sarin exposure versus control samples. We per-
formed background correction, quantile normalization, and
summarization using the robust multi-array average method
implemented in the BioConductor R-language suite of bioin-
formatics tools (Irizarry et al., 2003). With geneﬁlter, a
BioConductor package, we carried out non-speciﬁc ﬁltering
of the genes. Probe sets without Entrez ID or with low
variances across all microarrays based on inter-quartile range
were removed, and the number of replicates for each micro-
array that had a “Present” call was determined for each probe
set. Only probe sets for which at least 25% of the conditions
had “Present” calls for all replicates within a condition were
retained for further analysis. With the remaining genes, we
computed log2 expression values for treatment and control as
averages over replicates. After determining the average
intensity between the replicates, we calculated the log2 fold
changes (FC) for each gene as the difference between treat-
ment and corresponding control RMA expression levels (log
ratios).
4.2. Identifying genes relevant to seizing and non-seizing
rats
We used the rank product – a non-parametric, permutation
based method – to identify differentially expressed genes
(Breitling et al., 2004). In our analyses, we separately identi-
ﬁed signiﬁcantly activated (up-regulated) and suppressed
(down-regulated) genes using an FDR-corrected p-value of
0.05 as the statistical signiﬁcance cutoff. We considered up-
and down-regulated genes separately, as biological processes
are characterized by interacting, co-regulated proteins (Yu
et al., 2011). We carried out the rank product analyses
separately for each combination of brain region and time
point in either seizing or non-seizing rats. In addition, we
used R and Perl to analyze the DEGs and FCs of the genes.
4.3. Pathway enrichment analyses
To identify molecular pathways that were signiﬁcantly regu-
lated at each combination of brain region and time point in
seizing and non-seizing rats, we used the Database for
Annotation, Visualization, and Integrated Discovery (DAVID,
http://david.abcc.ncifcrf.gov/home.jsp) tool to perform Gene
Ontology (GO) analysis and KEGG pathway enrichment ana-
lysis (Huang et al., 2009). We considered GO terms and KEGG
pathways below a p-value of 0.05 to be signiﬁcantly enriched.
We used the DEGs identiﬁed from Section 4.2 as inputs for the
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up-regulated genes and down-regulated genes (unless other-
wise noted) in this set and carried out the pathway enrich-
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